Multi-center clinical trials and monitoring
Anju Gopan
Challenges of pharmacovigilance programme in our set up
Barna Ganguly
Detection and evaluation of drug safety signals in post marketing phase
Neha Vala
Data analytics in Pharmacovigilance
Amit Srivastava
Pharmacovigilance in India and emerging markets: An industry perspective
Shashidhar Swamy, Meenakshi Mourya, Ganesh Kadhe and Amey Mane
Role of pharmacovigilance in drug development
Prabhakar Reddy Veerareddy
Role of pharmacovigilance in health regulation
Ayesha Rubina
Artificial neural network: A data mining tool in pharmacovigilance
Prithviraj Chakraborty, Debarupa D Chakraborty and Amitava Ghosh
Pharmacovigilance and it?s challenges
Anant Khot
Gayatri Devi C, Usharani P and Aruna D
Retrospective analysis on Adverse Drug Reactions induced by antibiotics in a tertiary care centre
A Renuka, C Vasanthi and Darling Chellathai
Pharmacovigilance - A wake up for healthcare professionals and the public
Sagar D Kadam
Vanitha Rani N
An overview of the recent advances in the treatment of Parkinson?s disease
Swetha E S
Recent advances in breast cancer therapy
Bhanu Priya B and Basavanna P L
A retrospective study of eclampsia in a tertiary care centre
Mary Rohini Pentareddy, G Prasuna, Subbaratnam Y and Shailendra G
Using pharmacodynamics and pharmacokinetics during clinical practice to avoid drug overdose
Jamal Tashkandi Fanzca
European risk management plans: Current experience of the generics sector
John Barber
R Manavalan
Role of pharma industries in the improvement of pharmacovigilance system
Pranjal Bordoloi
Why do we need pharmacovigilance in India?
Ratinder Jhaj
Mala Kharkar and Suresh Bowalekar
Mohammad Wasif Khan
Raja Chakraverty and AmitavaGhosh
Early identification and prevention of drug-to-drug interactions in a tertiary care hospital
Radhika Soanker and Subbalaxmi M V S
End of the blockbuster model-What next?
Sreedhar D and Udupa N
Study on variations of Theophylline plasma concentrations with respect to time of administration
Mahvash Iram, Shobha Rani R H, Megha Bhat and Nalini Pais
Sandeep B
PV requirements in non ICH regions
Shoba Rajagopal
Balaji V, Chethan Kumar S, Shwetha E S and Geetha S
A study on analysis of fixed drug combinations widely prescribed in India
Bettina Lavanya Magdaline S, Vasanthi C and Darling Chellathai
A case of corticosteroid induced cushing?s syndrome reported to a tertiary care teaching hospital
G Sirisha
Role of risk management in pharmacovigilance
Manjunath H
Evaluation of the role of nephrotoxic drugs in contrast induced nephropathy
Sirisha Annavarapu, Dinesh Naidu, Karuna Sree and Y Venkata Rao
Singh S, Abidi A, Tewari S, Thadani S, Rai R K and Qadeer F
Cutaneous drug reactions reported in a dermatology outpatient clinic of a tertiary care hospital
Swathi Ratnam R, Prabhakar I, Usha Kiran P and B Balachandrudu
Chitra K, Shovan P and Mitisha S
Herbal medicine use and the emerging concern for ADR monitoring
Prashanth D
National pharmacovigilance programme
Geetha S, Swetha E S and Sathisha Aithal
Role of consumers in the patient?s safety profile of pharmacovigilance program
Atul Jain
Translation of pharmacogenomics into clinical practice of personalized psycho-therapeutics
Shakila Srikumar
Bakrudeen Ali Ahmed Abdul, MV Rao, ASRao and Rosna Mat Taha
Gunjan Jain
Frequency of ABO blood group and Rh-D factor among the donor population of Warangal
Nagaraju M and Rajendran S D
Evaluating the rationality of claims made in drug promotional literature in West Chennai
Pavithira Sekar, K Punnagai and Darling Chellathai David
The role of pharmacovigilance in biosimilars
Imran Maniyar
A case report on suspected calcium channel blocker induced hypothyroidism
Pruthvi D
Review of the softwares used in pharmacovigilance and clinical trials
Apoorva B M, Kiran L J and Chethan Kumar S
Prescribing patterns of antimicrobials in diabetic foot ulcer in a tertiary care hospital
Ramadi Prameela
Priyank Shah and Radha Yegnanarayan
Homa Gharaie , Mohammad Ali Raeessi, Jafar Aslani, Neda Raeessi, Ali Akbar Karimi Zarchi and Fereshteh Raeessi
Ankur A Bhute